Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19-Reference-Cited by-同舟云学术

Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19

Published:2020-06-17 Issue:8 Volume:39 Page:2475-2477
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Gazzaruso Carmine^ORCID,Carlo Stella Nicoletta,Mariani Giuseppe,Tamburlini Anna,Garini Pietro,Freddi Elena,Ravetto Carolina,Coppola Adriana,Gallotti Pietro

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-020-05239-5.pdf

Reference10 articles.

1. Di Gennaro F, Pizzol D, Marotta C et al (2020) Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. Int J Environ Res Public Health 17(8). https://doi.org/10.3390/ijerph17082690

2. Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R (2020) COVID-19 infection and rheumatoid arthritis: faraway, so close! Autoimmun Rev 19(5):102523

3. Quartuccio L, Valent F, Pasut E, Tascini C, Vita S (2020, 2020) Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine S1297-319X(20)30088-9. https://doi.org/10.1016/j.jbspin.2020.05.00

4. Ye C, Cai S, Shen G et al (2020, 2020) Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Ann Rheum Dis:annrheumdis-2020-217627. https://doi.org/10.1136/annrheumdis-2020-217627

5. Moiseev S, Avdeev S, Brovko M et al (2020, 2020) Rheumatic diseases in intensive care unit patients with COVID-19. Ann Rheum Dis:annrheumdis-2020-217676. https://doi.org/10.1136/annrheumdis-2020-217676

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID‐19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic;Internal Medicine Journal;2024-05-30

2. Coronavirus disease 2019 (COVID-19) infection in patients with rheumatic diseases: Clinical characteristics and relation to anti-rheumatic therapy;The Egyptian Rheumatologist;2023-10

3. Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation;Frontiers in Cardiovascular Medicine;2023-07-17

4. COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort;Rheumatology;2023-01-16

5. COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization;Rheumatology and Therapy;2022-12-02